Bio/Pharma News

AstraZeneca Reaches an Agreement to Acquire Actavis’ Respiratory Portfolio

February 06, 2015

AstraZeneca announced that it would strengthen its respiratory pipeline with the acquisition of Actavis’ branded respiratory business in the US and Canada.

FDA Accelerates Approval to Pfizer's Palbociclib

February 04, 2015

The cyclin-dependent kinase 4/6 inhibitor for the treatment of metastatic breast cancer was approved more than two months ahead of the prescription drug user fee goal date.

First Inhalable Insulin Comes to the US

February 04, 2015

Sanofi launched a rapidly absorbed, short-acting inhalable insulin in the US to help control type 1 and type 2 diabetes.

EMD Serono Announces Product Marketing Change

February 03, 2015

Merck announced that the responsibility for its diabetes and thyroid brands will be shifted back to EMD Serono in Russia, removing the responsibility from its marketing partner, Takeda.

Shantha Constructs Insulin Facility in India

February 03, 2015

The Shantha facility will be Sanofi's second, in addition to its site in Frankfurt, for production of Insuman insulin.

Precision Biologics Enlists EMD Millipore for Help with Upstream Process Development

February 02, 2015

EMD Millipore will provide process development services for Precision Biologics’ preclinical monoclonal antibody.

FDA Approves HIV Treatments from BMS and J&J

January 30, 2015

Bristol-Myers Squibb and Johnson & Johnson announced FDA-approval of Evotaz and Prezcobix, combination HIV-1 infection treatments.

AstraZeneca Partners with MD Anderson on Cancer Therapy Development

January 29, 2015

AstraZeneca and the University of Texas MD Anderson Cancer Center announced a plan to collaborate for the improvement of patient outcomes in clinical trials with investigational therapies.

Piramal Invests $30.6 Million in Coldstream Acquisition

January 26, 2015

Giovanni Caforio Named BMS CEO

January 21, 2015

Bristol-Myers Squibb has announced that Giovanni Caforio will be the company’s chief executive officer effective May 5; Lamberto Andreotti has been named chairman.